Study of GL701 in Men With Systemic Lupus Erythematosus
NCT00037128
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
GL701
Sponsor
Genelabs Technologies